Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-N05 for excessive daytime sleepiness in narcolepsy
NCT01681121Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Sep 2012
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solriamfetol in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Sep 2012; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT01681121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681121.